Children's Health Defense The Centers for Disease Control and Prevention warned of a shortage of a drug designed to protect newborns from severe cases of respiratory syncytial virus (RSV), but some doctors say avoiding that shot or the RSV vaccine during pregnancy is a good thing.
The Centers for Disease Control and Prevention (CDC) last week issued a health advisory warning pediatricians and parents of a shortage of a new drug designed to protect newborns from severe cases of respiratory syncytial virus (RSV) â just as cases of RSV are expected to rise nationwide.
A week after the health advisory was issued, parents and pediatricians are struggling to find the new drug, nirsevimab, administered to infants and toddlers up to age 2 as a shot under the brand name Beyfortus.
In July, the U.S. Food and Drug Administration approved the Beyfortus shot âto prevent RSV in babies and toddlers,â in time for the drugmaker to roll it out for the October-to-March RSV season.
Read Full Article Here…(childrenshealthdefense.org)
Home | Caravan to Midnight (zutalk.com)
Live Stream + Chat (zutalk.com)
